Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major

Tunisie Medicale

Volumn 88, Issue 2, 2010, Pages 123-

  Dhouib, N ^a   Turki, Z ^a   Mellouli, F ^a   Ouederni, M ^a   Yahiaoui, S ^a   Nagi, S ^a   Ben Slama, C ^a   Bejaoui, N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DEFEROXAMINE MESYLATE; FERRITIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; TESTOSTERONE;

ADULT; ANAMNESIS; BETA THALASSEMIA; CASE REPORT; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIET THERAPY; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; EXERCISE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INSULIN BLOOD LEVEL; LETTER; PALLOR; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 77649266985     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Farmaki K, Angelopoulous N, Anagnostopoulous G, Gotsis E, Rombopoulos G, Tolis G. Effect of enhanced iron chelation therapy on glucose metabolism in patients with ,-thalassaemia major. Br J Haematol. 2006; 134: 438-444.
2. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;16: 139-146.
3. Chern JP, Lin KH, Lu MY, Lin D, Lin KS, Chen JD, Fu CC. Abnormal glucose tolerance in transfusion-dependent beta thalassemic patients. Diabetes care. 2001; 24: 850-854.
4. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs.2003; 63: 1879-1894.
5. Kosecki SM, Rodgers PT, Adams MB .Glycaemic monitoring in diabetics with sickle cell plus beta-thalassemia haemoglobinopathy. Ann Pharmacother.2005; 39: 1557-1560.